Kevin Dat Vuong, M.A.

Instructor of Neurology

Graduate School

M.A. (1997) Binghamton University, New York

Clinical Interests

Movement disorders including Parkinson's disease, essential tremor, dystonia, Tourette's syndrome and Huntington's disease

Research Interests

Statistical analysis, database management and psychometrics in assessing the various components of movement disorders

Publications

Ondo WG, Meilak C, Vuong KD. Predictors of battery life for the Activa((R)) Soletra 7426 Neurostimulator. Parkinsonism Relat Disord 2007;:.
Ondo WG, Meilak C, Vuong KD. Predictors of battery life for the Activa Soletra 7426 Neurostimulator. Parkinsonism Relat Disord 2007;13:240-2.
Diamond A, Shahed J, Azher S, Dat-Vuong K, Jankovic J. Globus pallidus deep brain stimulation in dystonia. Mov Disord 2006;21:692-5.
Jankovic J, Vuong KD, Thomas M. Psychogenic tremor: long-term outcome. CNS Spectr 2006;11:501-8.
Thomas M, Vuong KD, Jankovic J. Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord 2006;12:382-7.
Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 2005;20:592-7.
Ondo WG, Wang A, Thomas M, Vuong KD. Evaluating factors that can influence spirography ratings in patients with essential tremor. Parkinsonism Relat Disord 2005;11:45-8.
Wan XH, Vuong KD, Jankovic J. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms. Chin Med Sci J 2005;20:44-7.
Brodsky H, Dat Vuong K, Thomas M, Jankovic J. Glabellar and palmomental reflexes in Parkinsonian disorders. Neurology 2004;63:1096-8.
Jankovic J, Madisetty J, Vuong KD. Essential tremor among children. Pediatrics 2004;114:1203-5.
Ondo W, Romanyshyn J, Vuong KD, Lai D. Long-term treatment of restless legs syndrome with dopamine agonists. Arch Neurol 2004;61:1393-7.
Ondo WG, Jimenez JE, Vuong KD, Jankovic J. An open-label pilot study of levetiracetam for essential tremor. Clin Neuropharmacol 2004;27:274-7.
Ondo WG, Vuong KD, Derman HS. Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia 2004;24:60-5.
Thomas M, Jankovic J, Suteerawattananon M, Wankadia S, Caroline KS, Vuong KD, Protas E. Clinical gait and balance scale (GABS): validation and utilization. J Neurol Sci 2004;217:89-99.
Hill AN, Jankovic J, Vuong KD, Donovan D. Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism. Mov Disord 2003;18:1190-2.
Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003;60:1186-8.
Kwak C, Dat Vuong K, Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 2003;18:1530-3.
Kwak C, Vuong KD, Jankovic J. Migraine headache in patients with Tourette syndrome. Arch Neurol 2003;60:1595-8.
Ondo WG, Sutton L, Dat Vuong K, Lai D, Jankovic J. Hearing impairment in essential tremor. Neurology 2003;61:1093-7.
Ondo WG, Levy JK, Vuong KD, Hunter C, Jankovic J. Olanzapine treatment for dopaminergic-induced hallucinations. Mov Disord 2002;17:1031-5.
Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59:421-4.
Ondo W, Dat Vuong K, Almaguer M, Jankovic J, Simpson RK. Thalamic deep brain stimulation: effects on the nontarget limbs. Mov Disord 2001;16:1137-42.
Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001;57:1392-6.
Ondo W, Hunter C, Vuong KD, Schwartz K, Jankovic J. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord 2000;15:678-82.
Ondo WG, Hunter C, Vuong KD, Jankovic J. The pharmacokinetic and clinical effects of tolcapone on a single dose of sublingual apomorphine in Parkinson's disease. Parkinsonism Relat Disord 2000;6:237-240.
Ondo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology 2000;55:1404-6.

Poster Presentations

Sitburana O, Rountree S, Vuong KD, Ondo W. Weight Change in Parkinson and Alzheimer Patients Taking Atypical Antipsychotic Drugs. Movement Disorder Society (MDS), 11th International Congress of Parkinson's Disease and Movement Disorders in Istanbul, Turkey (June 3-7, 2007).
Diamond AL, Vuong KD, Jankovic J. Deep Brain Stimulation of the Subthalamic Nucleus on Parkinson's Disease: Effects on Quality of Life. American Academy of Neurology (AAN), 59th Annual Meeting in Boston, Massachusetts (April 28 - May 5, 2007).
Azher SN, Vuong KD, Shahed J, Diamond AL, Jankovic J. Gait and Balance Assessment in Parkinsonian Disorders. Movement Disorder Society (MDS), 9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, Louisiana (March 5-8, 2005).
Diamond AL, Shahed J, Azher SN, Vuong KD, Jankovic J. Globus Pallidus Deep Brain Stimulation in Dystonia. Movement Disorder Society (MDS), 9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, Louisiana (March 5-8, 2005).
Hunter C, Vuong KD, Mejia N, Jankovic J. Tetrabenazine: Does Prior History of Depression Preclude this Drug as a Treatment Option?. Movement Disorder Society (MDS), 9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, Louisiana (March 5-8, 2005).
Mejia N, Vuong KD, Hunter C, Jankovic J. Medications Associated with the Onset of Tardive Dyskinesia. Movement Disorder Society (MDS), 9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, Louisiana (March 5-8, 2005).
Ondo WG, Meilak C, Vuong KD, Jankovic J. Predictors of Battery Life for the Activa® Soletra 7426 Neurostimulator. Movement Disorder Society (MDS), 9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, Louisiana (March 5-8, 2005).
Shahed J, Diamond AL, Vuong KD, Jankovic J. Characteristics of Parkinson's Disease in Patients with Childhood-onset Essential Tremor. Movement Disorder Society (MDS), 9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, Louisiana (March 5-8, 2005).
Silay Y, Jankovic J, Vuong KD, Almageur M, Ondo WG, Tintner R, Simpson Jr RK. The Safety of Deep Brain Stimulation in Patients with Parkinson's Disese, Essential Tremor, and Other Movement Disorders. American Neurological Association (ANA), 129th Annual Meeting in Toronto, Canada (Oct. 4-5, 2004).
Jankovic J, Hunter CB, Vuong KD. Safety and Efficacy of Tetrabenazine in the Treatment of Huntington's Disease and Other Choreas. Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders, 18th Annual Symposium in Toronto, Canada (Oct. 3, 2004).
Hunter C, Vuong KD, Mejia N, Jankovic J. Tetrabenazine, a Monoamine Depleter, Effective in the Treatment of Tourette Syndrome. Movement Disorder Society (MDS), 8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004).
Jankovic J, Hunter C, Mejia N, Vuong KD. Tetrabenazine: Effective Treatment for Tardive Dyskinesia. Movement Disorder Society (MDS), 8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004).
Silver GA, Vuong KD, Jankovic J. Young-Onset Versus Late-Onset Parkinson's Disease: Clinical Features and Disease Progression. Movement Disorder Society (MDS), 8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004).
Thomas M, Banuelos P, Vuong KD, Jankovic J. Long-Term Prognosis of Psychogenic Movement Disorders. Movement Disorder Society (MDS), 8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004).
Thomas M, Vuong KD, Jankovic J. Psychogenic Dystonia: Clinical Characteristics and Long-Term Progression. Movement Disorder Society (MDS), 8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004).
Vuong KD, Hunter C, Mejia N, Jankovic J. Safety and Efficacy of Tetrabenazine in Childhood Hyperkinetic Movement Disorders. Movement Disorder Society (MDS), 8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004).
Hunter CB, Vuong KD, Jankovic J. Long-Term Tolerability of Tetrabenazine in the Treatment of Hyperkinetic Movement Disorders. American Academy of Neurology (AAN), 56th Annual Meeting in San Francisco, California (April 24 - May 1, 2004).
Jankovic J, Madisetty J, Vuong KD. Essential Tremor in Children. American Academy of Neurology (AAN), 56th Annual Meeting in San Francisco, California (April 24 - May 1, 2004).
Jankovic J, Vuong KD, Thomas M. Psychogenic Tremor: Long-Term Outcome. American Academy of Neurology (AAN), 56th Annual Meeting in San Francisco, California (April 24 - May 1, 2004).
Silay YS, Vuong KD, Jankovic J. The Efficacy and Safety of Fluphenazine in Patients with Tourette Syndrome. American Academy of Neurology (AAN), 56th Annual Meeting in San Francisco, California (April 24 - May 1, 2004).
Jankovic J, Hunter CB, Vuong KD. Tetrabenazine in the Treatment of Chorea. American Society for Experimental NeuroTherapeutics (ASENT), 6th Annual Meeting in Bethesda, Maryland (March 11-13, 2004).
Ondo WG, Romanyshyn J, Vuong KD. Long Term Treatment of Restless Legs Syndrome with Dopamine Agonists. American Academy of Neurology (AAN), 55th Annual Meeting in Honolulu, Hawaii (March 29 - April 5, 2003).
Hill AN, Jankovic J, Vuong KD, Donovan D. Treatment of Hypophonia with Collagen Vocal Fold Augmentation in Patients with Parkinkinism. Movement Disorder Society (MDS), 7th International Congress of Parkinson's Disease and Movement Disorders in Miami, Florida (Nov. 10-14, 2002).
Hunter CB, Wang A, Vuong KD, Jankovic J. Age-Related Tolerability of Tetrabenazine. Movement Disorder Society (MDS), 7th International Congress of Parkinson's Disease and Movement Disorders in Miami, Florida (Nov. 10-14, 2002).
Hunter CB, Wang A, Vuong KD, Jankovic J. Tetrabenazine in the Treatment of Tourette Syndrome. Movement Disorder Society (MDS), 7th International Congress of Parkinson's Disease and Movement Disorders in Miami, Florida (Nov. 10-14, 2002).
Ondo WG, Wang A, Thomas M, Vuong KD. Evaluating Factors that can Influence Spirography Ratings in Patients with Essential Tremor. Movement Disorder Society (MDS), 7th International Congress of Parkinson's Disease and Movement Disorders in Miami, Florida (Nov. 10-14, 2002).
Tintner R, Almaguer M, Vuong KD, Ondo WG, Jankovic J, Sanghera M. Predictors of Response to Bilateral Subthalamic Nucleus Stimulation for Parkinson's Disease. Movement Disorder Society (MDS), 7th International Congress of Parkinson's Disease and Movement Disorders in Miami, Florida (Nov. 10-14, 2002).
Ondo WG, Vuong KD, Derman HS. Botulinum Toxin A (Botox) for Chronic Daily Headache: A Randomized Placebo-Controlled, Parallel Design Study. American Headache Society, 44th Annual Scientific Meeting in Seattle, Washington (June 21-23, 2002).
Jankovic J, Ahsan J, Vuong KD. Comparison of Immunogenicity of Old versus Current BOTOX in Cervical Dystonia. Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, International Conference in Hannover, Germany (June 8, 2002).
Atassi F, Vuong KD, Jankovic J, Ondo WG. The Prevalence of Restless Legs Syndrome in Patients with Parkinson's Disease. American Academy of Neurology (AAN), 53rd Annual Meeting in Philadelphia, Pennsylvania (May 5-11, 2001).
Ondo WG, Vuong KD, Jankovic J. Exploring the Relationship between Parkinson's Disease and Restless Legs Syndrome. American Academy of Neurology (AAN), 53rd Annual Meeting in Philadelphia, Pennsylvania (May 5-11, 2001).
Ondo WG, Hunter C, Vuong KD, Jankovic J. Olanzapine Treatment for Dopaminergic Induced Hallucinations. Movement Disorder Society (MDS), 6th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000).
Ondo WG, Vuong KD, Atassi F, Khan H, Kwak C, Jankovic J. Daytime Sleepiness in Patients with Parkinson's Disease. Movement Disorder Society (MDS), 6th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000).
Vuong KD, Ondo WG, Almaguer M, Simpson RK, Jankovic J. Unilateral Thalamic Deep Brain Stimulation for Essential Tremor and Parkinson's Disease: Effects of Stimulation on the Non-Target Limb and Rebound Augmentation. American Academy of Neurology (AAN), 52nd Annual Meeting in San Diego, California (April 29 - May 6, 2000).

Contact Information

Kevin Dat Vuong, MA
Manager, Information Technology
Department of Neurology
Baylor College of Medicine
One Baylor Plaza, MS NB302
Houston, Texas 77030

Tel: 713-798-5427
Fax: 713-798-3853
Email: